Back to results
US 2022/0178913 A1Published application
Novel cell line and uses thereof
AssigneeSenzagen AB
InventorsMalin Marie Lindstedt, Carl A K Borrebaeck, Henrik Johansson, Robin Gradin
Life of this patent
Estimating the term…
Abstract
The present invention provides a non-naturally occurring dendritic-like myeloid leukaemia cell according to ATCC Patent Deposit Designation PTA-123875, and methods and kits utilising such cells.
Claims31
A non-naturally occurring dendritic-like myeloid leukaemia cell according to ATCC Patent Deposit Designation PTA-123875.
(canceled)
(canceled)
(canceled)
(canceled)
16-21. (canceled)
(canceled)
(canceled)
31-33. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.